Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: An observational cohort study based on SEER-Medicare

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Griffiths, Robert I ^a,b,c   Danese, Mark D ^a   Gleeson, Michelle L ^a   Valderas, José M ^c  

^a Outcomes Insights Inc   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Breast cancer; Diabetes; Mortality; Previously undiagnosed; Risk factors; Stage; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 84871358665     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-613     Document Type: Article

References (50)

1. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007, 121:856-862. 10.1002/ijc.22717, 17397032.
2. Peairs KS, Barone BB, Snyder CF, Yeh H-C, Stein KB, Derr RL, Brancati FL, Wolff AC. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 2011, 29(1):40-46. 10.1200/JCO.2009.27.3011, 3055858, 21115865.
3. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K. The impact of type 2 diabetes mellitus on cancer-specific survival. Cancer 2012, 118:1353-1361. 10.1002/cncr.26420, 21800292.
4. Schrauder MG, Fasching PA, Habërle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, et al. Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol 2011, 137:975-983. 10.1007/s00432-010-0960-2, 21132511.
5. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP. Clinically defined type 2 diabetes mellitus and prognosis in early stage breast cancer. J Clin Oncol 2011, 29(1):54-60. 10.1200/JCO.2010.29.3183, 3055860, 21115861.
6. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 2009, 27(13):2170-2176. 10.1200/JCO.2008.17.5935, 2674004, 19307509.
7. Van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population-based analysis. Int J Cancer 2007, 120:1986-1992. 10.1002/ijc.22532, 17230509.
8. Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001, 285(7):885-892. 10.1001/jama.285.7.885, 11180731.
9. Zhou XH, Qiao Q, Zethilius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CDA, Heine RJ, Jousilahti P, Ruotolo G, , et al. for the DECODE Study Group Diabetes, prediabetes and cancer mortality. Diabetologia 2010, 53:1867-1876. 10.1007/s00125-010-1796-7, 20490448, for the DECODE Study Group.
10. Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012, Published online June 14, 2012.
11. Patnaik JL, Byers T, DiGuiseppi C, Dabela D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 2011, 13:R64. 10.1186/bcr2901, 3218953, 21689398.
12. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 2008, 109:389-395. 10.1007/s10549-007-9654-0, 17659440.
13. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005, 294:1765-1772. 10.1001/jama.294.14.1765, 16219879.
14. Du W, Simon MS. Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 2005, 91:243-248. 10.1007/s10549-005-0324-9, 15952057.
15. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 1999, 37(6):601-614. 10.1097/00005650-199906000-00009, 10386572.
16. Wolf I, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol 2005, 6:103-111. 10.1016/S1470-2045(05)01736-5, 15683819.
17. Giovannuci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care 2010, 33(7):1674-1685. 10.2337/dc10-0666, 2890380, 20587728.
18. DeCensi A, Gennari A. Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol 2011, 29(1):7-10. 10.1200/JCO.2010.32.3022, 21115871.
19. Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS. Screening mammogram utilization in women with diabetes. Diabetes Care 2001, 24(12):2049-2053. 10.2337/diacare.24.12.2049, 11723081.
20. McBean AM, Yu X. The underuse of screening services among elderly women with diabetes. Diabetes Care 2007, 30(6):1466-1472. 10.2337/dc06-2233, 17351285.
21. Keating NL, Landrum MB, Ayanian JZ, Winder EP, Guadagnoli E. The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 2004, 20:38-44.
22. Gornick ME, Eggers PW, Riley GF. Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. HSR: Health Services Res 2004, 39(5):1403-1427.
23. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005, 43:132-140. 10.1097/00005650-200502000-00006, 15655426.
24. Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008, 300(23):2754-2764. 10.1001/jama.2008.824, 3093051, 19088353.
25. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Medical Quality 1999, 14(6):270-277.
26. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000, 53:1258-1267. 10.1016/S0895-4356(00)00256-0, 11146273.
27. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32(2):287-294. 2628695, 19017771.
28. Danese MD, O'Malley C, Lindquist K, Gleeson M, Griffiths RI. An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol 2011, Epub ahead of print.
29. Executive summary: standards of medical care in diabetes - 2011. Diabetes Care 2011, 34(suppl. 1):S4-S10. 3006058, 21193627.
30. Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 2009, 8(6):909-915. 10.4161/cc.8.6.7933, 19221498.
31. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung M-C, Hortobagyi GN, Gonzalez-Angulo AM. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009, 27(20):3297-3302. 10.1200/JCO.2009.19.6410, 2736070, 19487376.
32. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003, 157(12):1092-1100. 10.1093/aje/kwg100, 12796045.
33. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002, 40:IV-18.
34. National Cancer Institute Overview of the SEER Program [Internet] 2011, Bethesda: National Cancer Institute, [Accessed 9/29/2011.] Available from: http://seer.cancer.gov/about/overview.html, National Cancer Institute.
35. National Cancer Institute Overview of the SEER Program [Internet] 2011, Bethesda: National Cancer Institute, [Accessed 9/29/2011.] Available from: http://healthservices.cancer.gov/seermedicare/overview/linked.html, National Cancer Institute.
36. SEER program code manual 1998, Bethesda: Cancer Statistics Branch, Surveillance Program, Div of Cancer Control and Pop Sciences, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Dept of Health and Human Services, Fritz A, Ries L, 3.
37. Klabunde CN, Legler JM, Warren JL, Baldwin L-M, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007, 17:584-590. 10.1016/j.annepidem.2007.03.011, 17531502.
38. National Cancer Institute Overview of the SEER Program [Internet] 2010, Bethesda: National Cancer Institute, [Accessed 8/27/10.] Available from: http://healthservices.cancer.gov/seermedicare/program/remove.ruleout.dxcodes.macro.txt, National Cancer Institute.
39. National Cancer Institute Overview of the SEER Program [Internet] 2010, Bethesda: National Cancer Institute, [Accessed 8/27/10.] Available from: http://healthservices.cancer.gov/seermedicare/program/charlson.comorbidity.macro.txt, National Cancer Institute.
40. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. 10.1016/0021-9681(87)90171-8, 3558716.
41. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613-619. 10.1016/0895-4356(92)90133-8, 1607900.
42. Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994, 47:249-260. 10.1016/0895-4356(94)90006-X, 8138835.
43. Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2010, 28(13):2191-2197. 10.1200/JCO.2009.25.4052, 20351329.
44. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002, 40(8 Suppl):IV-55-IV-61.
45. National Cancer Institute Procedure Codes for SEER Medicare Analysis [Internet] 2012, Bethesda: National Cancer Institute, [Accessed 5/17/2012.] Available from: http://healthservices.cancer.gov/seermedicare/considerations/procedure_codes.html, National Cancer Institute.
46. ResDAC. Research Data Assistance Center CMS 301: Using SEER/Medicare data for research 2008, MN: ResDAC, Minneapolis, ResDAC. Research Data Assistance Center.
47. Glymour MM, Greenland S. Causal diagrams. Modern epidemiology 2008, 183-209. Philadelphia: Lippincott Williams and Wilkins, Rothman KJ, Greenland S, Lash TL, Third Edition.
48. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004, 15(5):615-625. 10.1097/01.ede.0000135174.63482.43, 15308962.
49. Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, Poole C. llustrating bias due to conditioning on a collider. Int J Epidemiol 2010, 39:417-420. 10.1093/ije/dyp334, 2846442, 19926667.
50. Ashkenazy R, Abrahamson MJ. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med 2006, 21:386-392. 1484724, 16686819.